772
Views
10
CrossRef citations to date
0
Altmetric
Poison Centre Research

Management of severe bupropion poisoning with intravenous lipid emulsion

, , &
Pages 51-54 | Received 05 Mar 2017, Accepted 30 May 2017, Published online: 23 Jun 2017

References

  • Heise CW, Skolnik AB, Raschke RA, et al. Two cases of refractory cardiogenic shock secondary to bupropion successfully treated with veno-arterial extracorporeal membrane oxygenation. J Med Toxicol. 2016;12:301–304.
  • Sirianni AJ, Osterhoudt KC, Calello DP, et al. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med. 2008;51:412-5–415.e1.
  • Cole JB, Stellpflug SJ, Engebretsen KM. Asystole immediately following intravenous fat emulsion for overdose. J Med Toxicol. 2014;10:307–310.
  • Cave G, Harvey M. Lipid emulsion therapy in lipophilic drug toxicity. Ann Emerg Med. 2008;51:449–450.
  • Gosselin S, Hoegberg LC, Hoffman RS, et al. Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning. Clin Toxicol. 2016;1–25:167–193.
  • Livshits Z, Feng Q, Chowdhury F, et al. Life-threatening bupropion ingestion: is there a role for intravenous fat emulsion? Basic Clin Pharmacol Toxicol. 2011;109:418–422.
  • Cave G, Harvey M. Intravenous lipid emulsion as antidote beyond local anesthetic toxicity: a systematic review. Acad Emerg Med. 2009;16:815–824.
  • Hayes BD, Gosselin S, Calello DP, et al. Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration. Clin Toxicol. 2016;54:365–404.
  • Bucklin MH, Gorodetsky RM, Wiegand TJ. Prolonged lipemia and pancreatitis due to extended infusion of lipid emulsion in bupropion overdose. Clin Toxicol. 2013;51:896–898.
  • Levine M, Hoffman RS, Lavergne V, et al. Systematic review of the effect of intravenous lipid emulsion therapy for non-local anesthetics toxicity. Clin Toxicol. 2016;54:194–221.
  • Hurley W, Hanlon P. Lipid emulsion as an antidote at the Washington Poison Center; Use in carbamazepine, flecanide, hydroxychloroquine, bupivacaine, and bupropion (Abstract). Clin Toxicol. 2009;47:729–730.
  • Shenoi AN, Gertz SJ, Mikkilineni S, et al. Refractory hypotension from a massive bupropion overdose successfully treated with extracorporeal membrane oxygenation. Pediatr Emerg Care. 2011;27:43–45.
  • Tolentino S, Gharpure V, Tsifansky M. Successful use of lipid infusion and plasmapharesis after massive bupropion overdose (Abstract). Crit Care Med. 2013;41:A1173.
  • Fettiplace MR, Akpa BS, Rubinstein I, et al. Confusion about infusion: rational volume limits for intravenous lipid emulsion during treatment of oral overdoses. Ann Emerg Med. 2015;66:185–188.
  • Weinberg G. LipidRescue Resuscitation [internet]. [cited 2008 Dec 9]. Available from: www.LipidRescue.org, 2012.
  • Kryshtal DO, Dawling S, Seger D, et al. In vitro studies indicate intravenous lipid emulsion acts as lipid sink in verapamil poisoning. J Med Toxicol. 2016;12:165–171.
  • Huang Q, Huang C, Zhao Y, et al. LPS-stimulated RAW264.7 macrophage CAT-2-mediated l-arginine uptake and nitric oxide biosynthesis is inhibited by omega fatty acid lipid emulsion. J Surg Res. 2013;179:e211–e217.
  • Partownavid P, Umar S, Li J, et al. Fatty-acid oxidation and calcium homeostasis are involved in the rescue of bupivacaine-induced cardiotoxicity by lipid emulsion in rats. Crit Care Med. 2012;40:2431–2437.
  • Christian MR, Pallasch EM, Wahl M, et al. Lipid rescue 911: are poison centers recommending intravenous fat emulsion therapy for severe poisoning? J Med Toxicol. 2013;9:231–234.
  • Lenkey N, Karoly R, Lukacs P, et al. Classification of drugs based on properties of sodium channel inhibition: a comparative automated patch-clamp study. PLoS One. 2010;5:e15568.
  • Desai N, et al. Rapid reversal of prolonged hemodynamic collapse due to multi-drug overdose using intravenous 20% fat emulsion (Abstract). Clin Toxicol. 2012;50:364.
  • Balit CR, Lynch CN, Isbister GK. Bupropion poisoning: a case series. Med J Aust. 2003;178:61–63.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.